Peter S Klein Denali Therapeutics Inc. (DNLI) insider trading activity
Peter S Klein is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 27,533 shares of DNLI, which is worth approximately $400,054. The most recent transaction as insider was on Jun 03, 2025, when has been sold 6,037 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
27.5K
28.08%
3M change
28.08%
12M change
Total Value Held
$400,054
Peter S Klein Transaction History
Also insider at
PSK
Peter S Klein
Director
Seattle, WA